Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by MartyDon Jan 07, 2024 6:07pm
121 Views
Post# 35814825

RE:RE:RE:RE:Online Webinars

RE:RE:RE:RE:Online WebinarsI'm thinking Ascend is 50k users, they have to be brought online. 4.0 comes out April maybe? A couple of multiple unit buyers like Mayo, Rush, etc and you've got what you're looking for, but VPT has to keep bringing it all together. If a hospital is not interested in buying a VPT unit, they're not looking for a competitor either. They're not ready for AI.  If you're on the forefront of medical advancement,  VPT is already within your sights.  You can buy one now or fall behind by waiting for another company's rollout.  Most important for VPT is to make every new user's experience just right.  A couple of bad experiences because you sold more units than you can support because investors were clamoring for sales and you opened the door for a competitor to get traction.  I'd love for VPT to make strategic sales before making mass sales.  I can wait for mass sales in 2025. 
<< Previous
Bullboard Posts
Next >>